By using multiple in vitro and in vivo assays, we figured out that higher STYK1 expression is related to poor pancreatic cancer survival and that STYK1 depletion suppresses pancreatic cancer cell development. The gene discussed is STYK1; the disease is familial pancreatic carcinoma.